San Rafael, CA, United States of America

Christopher G Salentine

This inventor holds 11 USPTO granted patents and 3 published patent applications. Top assignees: Chevron Research Company, Biotie Therapies Corporation, Skinnovative Dermatologic Concepts, L.l.c.. Active years: 1983-2021.

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 72.7

Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 123(Granted Patents)

Location History:

Walnut Creek, CA (US) (1983)
Mill Valley, CA (US) (1984 - 1987)
San Rafael, CA (US) (1988 - 2021)

Company Filing History:

6 out of 1,860

Chevron Research Company

patents

3 out of 28

Biotie Therapies Corporation

patents

1 out of 1

Skinnovative Dermatologic Concepts, L.l.c.

patent

4. 1 out of 38

Spectrum Pharmaceuticals, Inc.

patents

Years Active: 1983-2021

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10973784 - Compositions and methods for treating Alzheimer's disease and Parkinson's disease (2021-04-13),

2. 10653699 - Controlled-release tozadenant formulations (2020-05-19),

3. 10314798 - Compositions and methods for treating Alzheimer's disease and Parkinson's disease (2019-06-11),

4. 8815953 - Formulations of vitamin K analogs for topical use (2014-08-26),

5. 6217852 - Personal cleansing compositions having photoprotective agents (2001-04-17),

6. 4717490 - Synergistic combination of alkali metal borates, sulfur compounds, (1988-01-05),

7. 4640827 - Trihydrated potassium triborate and process for reacting two borates in (1987-02-03),

8. 4575431 - Lubricant composition containing a mixture of neutralized phosphates (1986-03-11),

9. 4459215 - Synergistic combination of alkali metal borates, sulfur compound, and (1984-07-10),

10. 4431552 - Lubricant composition containing an alkali-metal borate and a mixture of (1984-02-14),

11. 4384967 - Lubricant composition containing an alkali metal borate and a (1983-05-24),

Title: Christopher G. Salentine: Innovator in Pharmaceutical Treatments

Introduction

Christopher G. Salentine is a notable inventor based in San Rafael, California, recognized for his contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made significant strides in developing treatments for neurodegenerative diseases.

Latest Patents

Salentine's latest patents include innovative compositions and methods for treating Alzheimer's disease and Parkinson's disease. One of his inventions involves tablets for oral administration that contain a therapeutically effective amount of SYN120 or a pharmaceutically acceptable salt thereof, designed to be substantially free of lactose. This invention aims to provide effective treatment options for patients suffering from these debilitating conditions. Another significant patent focuses on controlled-release tozadenant formulations, which provide a composition containing tozadenant and cellulose ether. This formulation is designed to ensure specific dissolution rates over time, enhancing the treatment efficacy for Parkinson's disease.

Career Highlights

Throughout his career, Salentine has worked with prominent organizations, including Chevron Research Company and Biotie Therapies Corporation. His experience in these companies has contributed to his expertise in pharmaceutical research and development.

Collaborations

Salentine has collaborated with notable professionals in his field, including Thomas R. Malefyt and Stuart R. Gildenberg. These collaborations have likely enriched his work and led to advancements in his research endeavors.

Conclusion

Christopher G. Salentine stands out as an influential inventor in the pharmaceutical industry, particularly in the development of treatments for Alzheimer's and Parkinson's diseases. His innovative patents and career achievements reflect his commitment to improving patient care through scientific advancements.